Suanfarma Suanfarma

X

224323-51-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
224323-51-7
Also known as: 224323-51-7, 4-(2-fluoro-4-isocyanatophenyl)morpholine, Morpholine, 4-(2-fluoro-4-isocyanatophenyl)-, Mfcd23381074, Schembl2586326, Dtxsid601269132
Molecular Formula
C11H11FN2O2
Molecular Weight
222.22  g/mol
InChI Key
JFYQLZHULWIALT-UHFFFAOYSA-N

1 2D Structure

224323-51-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-(2-fluoro-4-isocyanatophenyl)morpholine
2.1.2 InChI
InChI=1S/C11H11FN2O2/c12-10-7-9(13-8-15)1-2-11(10)14-3-5-16-6-4-14/h1-2,7H,3-6H2
2.1.3 InChI Key
JFYQLZHULWIALT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1COCCN1C2=C(C=C(C=C2)N=C=O)F
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 224323-51-7

2. 4-(2-fluoro-4-isocyanatophenyl)morpholine

3. Morpholine, 4-(2-fluoro-4-isocyanatophenyl)-

4. Mfcd23381074

5. Schembl2586326

6. Dtxsid601269132

7. 3-fluoro4-morpholinylphenylisocyanate

8. Zinc81119932

9. 3-fluoro-4-morpholinophenyl Isocyanate

10. 3-fluoro-4-morpholinylphenylisocyanate

11. Akos028108837

12. As-33228

13. 3-fluoro-4-(morpholinyl)phenyl Isocyanate

14. J3.527.271b

15. A856735

2.3 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 222.22 g/mol
Molecular Formula C11H11FN2O2
XLogP32.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass222.08045576 g/mol
Monoisotopic Mass222.08045576 g/mol
Topological Polar Surface Area41.9 Ų
Heavy Atom Count16
Formal Charge0
Complexity275
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
168828-82-8
Linezolid
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001....
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001. It came from a subsidiary company of China National Pharmaceutical Industry Company affiliated to China National Pharmaceutical Group (CNPIC). BJ Zhongshuo runs a medicine R&D centre in Beijing Economic-Technological Development Area with over 20 experienced specialists and a batch of advanced equipment for experiment and detection. The centre deals with the R&D for innovated drugs and Generic drugs as well as the optimization and improvement on exiting products. The R&D centre is now able to deal with 10-15 new products per year.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
174649-09-3
Linezolid
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001....
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001. It came from a subsidiary company of China National Pharmaceutical Industry Company affiliated to China National Pharmaceutical Group (CNPIC). BJ Zhongshuo runs a medicine R&D centre in Beijing Economic-Technological Development Area with over 20 experienced specialists and a batch of advanced equipment for experiment and detection. The centre deals with the R&D for innovated drugs and Generic drugs as well as the optimization and improvement on exiting products. The R&D centre is now able to deal with 10-15 new products per year.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY